Article info
Original research
Homologous recombination deficiency in newly diagnosed FIGO stage III/IV high-grade epithelial ovarian cancer: a multi-national observational study
- Correspondence to Dr Robert D Morgan, The Christie NHS Foundation Trust, Manchester, UK; robert.morgan7{at}nhs.net
Citation
Homologous recombination deficiency in newly diagnosed FIGO stage III/IV high-grade epithelial ovarian cancer: a multi-national observational study
Publication history
- Received December 12, 2022
- Accepted April 7, 2023
- First published April 18, 2023.
Online issue publication
October 18, 2023
Article Versions
- Previous version (7 August 2023).
- Previous version (7 August 2023).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2023. No commercial re-use. See rights and permissions. Published by BMJ.